Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-17

Clinical Trial Update: Effect of Basal-Bolus Closed-Loop Co-Administration of Insulin and Pramlintide on Improving the Glycemic Control in Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial investigating basal-bolus closed-loop co-administration of insulin and pramlintide for glycemic control in adults with Type 1 diabetes; study comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin (insulin)
  • pramlintide (pramlintide)

Snippet

Sponsor: McGill University | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED